131.75
price up icon0.05%   0.06
after-market 시간 외 거래: 131.78 0.03 +0.02%
loading
전일 마감가:
$131.69
열려 있는:
$131.75
하루 거래량:
1.01M
Relative Volume:
0.37
시가총액:
$14.03B
수익:
$612.78M
순이익/손실:
$-86.37M
주가수익비율:
-151.44
EPS:
-0.87
순현금흐름:
$-62.91M
1주 성능:
+0.11%
1개월 성능:
+2.73%
6개월 성능:
+79.74%
1년 성능:
+88.97%
1일 변동 폭
Value
$131.71
$131.79
1주일 범위
Value
$131.51
$131.79
52주 변동 폭
Value
$64.09
$131.79

Intra Cellular Therapies Inc Stock (ITCI) Company Profile

Name
명칭
Intra Cellular Therapies Inc
Name
전화
(646) 440-9333
Name
주소
135 ROUTE 202/206, BEDMINSTER, NY
Name
직원
0
Name
트위터
Name
다음 수익 날짜
2024-10-30
Name
최신 SEC 제출 서류
Name
ITCI's Discussions on Twitter

ITCI을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Drug Manufacturers - Specialty & Generic icon
ITCI
Intra Cellular Therapies Inc
131.75 14.03B 612.78M -86.37M -62.91M -0.87
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
165.02 73.07B 9.26B 2.49B 2.30B 5.47
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
15.14 47.43B 30.25B 1.37B 5.08B 0.4257
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
10.12 45.72B 14.35B 1.85B 0 0.4023
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
15.49 17.75B 16.54B -1.64B 749.00M -1.45

Intra Cellular Therapies Inc Stock (ITCI) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2025-02-24 다운그레이드 Mizuho Outperform → Neutral
2025-01-31 다운그레이드 Canaccord Genuity Buy → Hold
2024-09-06 업그레이드 Piper Sandler Neutral → Overweight
2024-01-03 개시 Robert W. Baird Outperform
2023-12-11 개시 TD Cowen Outperform
2023-04-20 개시 Morgan Stanley Overweight
2022-08-22 다운그레이드 Goldman Buy → Neutral
2022-07-07 개시 Mizuho Buy
2022-06-14 개시 UBS Buy
2022-04-22 개시 Piper Sandler Neutral
2022-02-16 개시 Goldman Buy
2021-09-23 개시 Needham Buy
2020-12-15 개시 BofA Securities Buy
2020-12-10 개시 Goldman Buy
2020-02-20 개시 Evercore ISI Outperform
2020-01-31 다운그레이드 JP Morgan Overweight → Neutral
2019-12-24 재확인 Canaccord Genuity Buy
2019-08-12 개시 Jefferies Buy
2018-02-26 개시 JP Morgan Overweight
2018-02-08 개시 RBC Capital Mkts Outperform
2017-12-15 개시 Canaccord Genuity Buy
2017-11-08 업그레이드 SunTrust Hold → Buy
2017-09-07 업그레이드 Piper Jaffray Neutral → Overweight
2017-08-30 업그레이드 Ladenburg Thalmann Neutral → Buy
2017-08-24 업그레이드 JMP Securities Mkt Perform → Mkt Outperform
2017-08-23 업그레이드 Leerink Partners Mkt Perform → Outperform
2017-05-02 다운그레이드 Ladenburg Thalmann Buy → Neutral
2017-05-02 다운그레이드 Leerink Partners Outperform → Mkt Perform
2017-05-01 다운그레이드 Piper Jaffray Overweight → Neutral
2016-12-16 개시 Cantor Fitzgerald Overweight
2016-09-29 재확인 RBC Capital Mkts Outperform
2016-09-29 다운그레이드 SunTrust Buy → Neutral
모두보기

Intra Cellular Therapies Inc 주식(ITCI)의 최신 뉴스

pulisher
04:28 AM

Intra-Cellular Therapies Shareholders Approve Johnson & Johnson Merger - Investing.com

04:28 AM
pulisher
04:13 AM

Intra-Cellular Therapies: These Are 5 Critical Challenges Threatening Its Expansion Plans! - Smartkarma

04:13 AM
pulisher
Mar 19, 2025

Intra-Cellular Therapies announces proxy statement supplement By Investing.com - Investing.com South Africa

Mar 19, 2025
pulisher
Mar 18, 2025

Intra-Cellular Therapies announces proxy statement supplement - Investing.com

Mar 18, 2025
pulisher
Mar 18, 2025

Intra-Cellular Therapies stockholder filed lawsuit against co, board in NY Supreme Court - Marketscreener.com

Mar 18, 2025
pulisher
Mar 18, 2025

Intra-Cellular Therapies Stock Hits All-Time High of $131.47 By Investing.com - Investing.com UK

Mar 18, 2025
pulisher
Mar 18, 2025

Intra-Cellular Therapies (ITCI): Among the Best Biotech Stocks to Buy According to Billionaires - Yahoo Finance

Mar 18, 2025
pulisher
Mar 14, 2025

US Bancorp DE Sells 4,330 Shares of Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) - Defense World

Mar 14, 2025
pulisher
Mar 12, 2025

Scrip M&A Podcast: Looking At M&A Activity As Q1 Nears A Close - Scrip

Mar 12, 2025
pulisher
Mar 12, 2025

Intra-Cellular Therapies (NASDAQ:ITCI) Now Covered by StockNews.com - Defense World

Mar 12, 2025
pulisher
Mar 11, 2025

Intra-Cellular Therapies Stock Hits All-Time High of $131.37 By Investing.com - Investing.com Australia

Mar 11, 2025
pulisher
Mar 11, 2025

Intra-Cellular Therapies Stock Hits All-Time High of $131.37 - Investing.com

Mar 11, 2025
pulisher
Mar 11, 2025

Jones Financial Companies Lllp Acquires 2,750 Shares of Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) - Defense World

Mar 11, 2025
pulisher
Mar 11, 2025

Charles Schwab Investment Management Inc. Increases Position in Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) - Defense World

Mar 11, 2025
pulisher
Mar 11, 2025

Long Term Trading Analysis for (ITCI) - Stock Traders Daily

Mar 11, 2025
pulisher
Mar 09, 2025

Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) Shares Purchased by Bank of New York Mellon Corp - Defense World

Mar 09, 2025
pulisher
Mar 08, 2025

Lisanti Capital Growth LLC Increases Stock Holdings in Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) - MarketBeat

Mar 08, 2025
pulisher
Mar 07, 2025

Intra-Cellular deal, Axsome settlement drive neurological index recovery - BioWorld Online

Mar 07, 2025
pulisher
Mar 07, 2025

Intra-Cellular Therapies, Inc. to Host Earnings Call - ACCESS Newswire

Mar 07, 2025
pulisher
Mar 06, 2025

J&J to stop studies of depression drug due to low effectiveness - Reuters.com

Mar 06, 2025
pulisher
Mar 05, 2025

Johnson & Johnson: No More Tears, Just Gains In Intra-Cellular Acquisition - Seeking Alpha

Mar 05, 2025
pulisher
Mar 05, 2025

Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) Receives Average Recommendation of “Hold” from Brokerages - Defense World

Mar 05, 2025
pulisher
Mar 04, 2025

Intra-Cellular Therapies (NASDAQ:ITCI) Coverage Initiated at StockNews.com - Defense World

Mar 04, 2025
pulisher
Mar 03, 2025

Intra-Cellular Therapies progresses in Johnson & Johnson merger By Investing.com - Investing.com Canada

Mar 03, 2025
pulisher
Mar 03, 2025

Intra-Cellular Therapies progresses in Johnson & Johnson merger - Investing.com

Mar 03, 2025
pulisher
Mar 01, 2025

Intra-Cellular Therapies, Inc. (ITCI): Among the Best Psychedelic Stocks to Buy in 2025 - Yahoo Canada Finance

Mar 01, 2025
pulisher
Mar 01, 2025

GW&K Investment Management LLC Sells 6,734 Shares of Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) - MarketBeat

Mar 01, 2025
pulisher
Mar 01, 2025

Phocas Financial Corp. Has $241,000 Position in Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) - MarketBeat

Mar 01, 2025
pulisher
Mar 01, 2025

Equities Analysts Offer Predictions for ITCI FY2025 Earnings - MarketBeat

Mar 01, 2025
pulisher
Feb 28, 2025

12 Best Psychedelic Stocks to Buy in 2025 - Insider Monkey

Feb 28, 2025
pulisher
Feb 28, 2025

Intra-Cellular Therapies (NASDAQ:ITCI) Reaches New 12-Month HighStill a Buy? - MarketBeat

Feb 28, 2025
pulisher
Feb 28, 2025

Intra-Cellular Therapies Stock Soars to All-Time High of $128.01 - MSN

Feb 28, 2025
pulisher
Feb 28, 2025

Where are the Opportunities in (ITCI) - Stock Traders Daily

Feb 28, 2025
pulisher
Feb 28, 2025

Wealthspire Advisors LLC Acquires New Position in Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) - MarketBeat

Feb 28, 2025
pulisher
Feb 28, 2025

ING Groep NV Purchases Shares of 12,500 Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) - MarketBeat

Feb 28, 2025
pulisher
Feb 28, 2025

Intra-Cellular Therapies (NASDAQ:ITCI) Stock Rating Lowered by Mizuho - MarketBeat

Feb 28, 2025
pulisher
Feb 28, 2025

HealthInvest Partners AB Sells 13,440 Shares of Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) - MarketBeat

Feb 28, 2025
pulisher
Feb 27, 2025

Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) Shares Purchased by Ieq Capital LLC - MarketBeat

Feb 27, 2025
pulisher
Feb 27, 2025

New York State Common Retirement Fund Has $6.40 Million Holdings in Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) - MarketBeat

Feb 27, 2025
pulisher
Feb 26, 2025

Intra-Cellular Therapies Stock Hits All-Time High of $129 By Investing.com - Investing.com Australia

Feb 26, 2025
pulisher
Feb 26, 2025

Intra-Cellular Therapies Stock Hits All-Time High of $129 - Investing.com

Feb 26, 2025
pulisher
Feb 25, 2025

INTRA-CELLULAR THERAPIES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Intra-Cellular Therapies, Inc.ITCI - Business Wire

Feb 25, 2025
pulisher
Feb 25, 2025

ITCI Q4 Loss Wider Than Expected, Revenues Top on Higher Caplyta Sales - MSN

Feb 25, 2025
pulisher
Feb 24, 2025

ITCI Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Intra-cellular Therapies, Inc. Is Fair to Shareholders - The Bakersfield Californian

Feb 24, 2025
pulisher
Feb 24, 2025

Intra-Cellular Therapies Reports Strong 2024 Growth - TipRanks

Feb 24, 2025
pulisher
Feb 24, 2025

This Conagra Brands Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Monday - Benzinga

Feb 24, 2025
pulisher
Feb 24, 2025

Mizuho cuts Intra-Cellular stock rating, lowers price target - Investing.com India

Feb 24, 2025
pulisher
Feb 24, 2025

Mizuho Downgrades Intra-Cellular Therapies to Neutral From Outperform, Lowers Price Target to $132 From $140 - Marketscreener.com

Feb 24, 2025
pulisher
Feb 24, 2025

StockNews.com Initiates Coverage on Intra-Cellular Therapies (NASDAQ:ITCI) - Defense World

Feb 24, 2025
pulisher
Feb 23, 2025

Intra-Cellular Therapies (NASDAQ:ITCI) Sets New 52-Week HighWhat's Next? - MarketBeat

Feb 23, 2025
pulisher
Feb 22, 2025

Allspring Global Investments Holdings LLC Raises Stake in Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) - Defense World

Feb 22, 2025

Intra Cellular Therapies Inc (ITCI) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$114.00
price down icon 0.39%
$8.84
price down icon 1.34%
$15.49
price down icon 1.27%
$97.04
price down icon 1.41%
$33.53
price down icon 0.47%
자본화:     |  볼륨(24시간):